Ulcerative Colitis (ABI-M201-101)

A randomized, double-blind, placebo-controlled, multi-center Phase 1b study to evaluate the safety, efficacy and microbiological response of orally administered ABI-M201 in subjects with mildly-to-moderately active Ulcerative Colitis with ongoing Mesalamine treatment. Register Today!

Atopic Dermatitis (B7451050)

A phase 3B randomized, double-blind, double-dummy, active controlled multi-center study assessing the efficacy and safety of Abrocitinib compared with Dupilumab in adult participants on background topical therapy with moderate to severe atopic dermatitis. Register Today!.

Endometriosis (P19-933)

Real-world experience of elagolix for the treatment of endometriosis in Canada: an observational cohort study (GRACE) Register Today!

Eczema in Adults & Adolescents (M16-813)

Atopic dermatitis or eczema as it is commonly known, is a condition that makes your skin red and itchy. The disease is common in children but can also occur at any age. Eczema is a chronic condition that tends to flare up periodically. There is currently no cure for eczema, but treatments and self-care measures…

Asthma in Adults and Children (AV003 – MANDALA)

According to Asthma Canada, the medical definition of asthma is simple, but the condition itself is quite complex. Doctors define asthma as a “chronic inflammatory disease of the airway” that causes the following symptoms: – Shortness of breath – Chest tightness – Coughing – Wheezing Asthma has no set pattern, it’s symptoms can be mild,…

Crohn’s Disease (M14-433/431/430)

Crohn’s disease is an inflammatory bowel disease (IBD). It causes inflammation of the lining of your digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition. Inflammation caused by Crohn’s disease can involve different areas of the digestive tract in different people. The inflammation caused by Crohn’s disease often spreads…